Android Apple

Kymera Therapeutics, Inc. (KYMR) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$40.82

north_east $0.03 (0.07%)
Day's range
$40.14
Day's range
$41.71

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
12/05/2024 BMO Capital Etzer Darout $55.00 $44.08   24.77%
12/02/2024 Wells Fargo Derek Archila $57.00 $48.54   17.44%
09/27/2024 Oppenheimer Jeff Jones $56.00 $49.47   13.2%
08/26/2024 Wolfe Research Andy Chen $65.00 $47.78   36.04%
08/08/2024 H.C. Wainwright Andrew Fein $60.00 $40.31   48.85%
06/17/2024 H.C. Wainwright Andrew Fein $46.00 $32.29   42.46%
05/23/2024 Piper Sandler Edward Tenthoff $56.00 $34.84   60.76%
05/03/2024 Oppenheimer Jeff Jones $52.00 $36.30   43.25%
No analyst forecast available for this stock.

Kymera Therapeutics, Inc. FAQ's

What analysts cover Kymera Therapeutics, Inc.?

Kymera Therapeutics, Inc. has been rated by research analysts at BMO Capital, Wells Fargo, Oppenheimer, Wolfe Research, H.C. Wainwright, Piper Sandler in the past 90 days.

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.